Literature DB >> 7674228

The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis.

M R Golden1, R S Katz, R A Balk, H E Golden.   

Abstract

OBJECTIVE: To test the hypothesis that preexisting lung disease is a risk factor for the development of methotrexate (MTX) pneumonitis in patients with rheumatoid arthritis (RA) treated with low dose MTX.
METHODS: We measured the proportion of patients with and without preexisting lung disease who developed MTX pneumonitis in a historical cohort from a university affiliated rheumatology private practice in Chicago. Patients comprised 93 women and 32 men with RA treated with MTX for any period of time between January, 1980 and July, 1989.
RESULTS: MTX pneumonitis occurred in 4 of 77 patients without preexisting lung disease (5.2%) and 5 of 29 (17.2%) patients with preexisting lung disease (p = 0.0610, Fisher's exact test). Five of 24 (20.1%) patients with preexisting lung disease characterized by the report of an abnormal chest radiograph developed MTX pneumonitis (p = 0.2328, Fisher's exact test) and 4 of 16 (25%) patients with interstitial infiltrates reported on their chest radiograph developed MTX pneumonitis (p = 0.0276, Fisher's exact test).
CONCLUSION: The presence of preexisting lung disease characterized by radiographic interstitial infiltrates predisposes patients with RA to develop MTX pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674228

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area.

Authors:  J Hamilton; I B McInnes; E A Thomson; D Porter; J A Hunter; R Madhok; H A Capell
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 2.  Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?

Authors:  Vasco C Romão; Aurea Lima; Miguel Bernardes; Helena Canhão; João Eurico Fonseca
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD).

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Takeshi Yoshikawa; Shinichiro Seki
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 4.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

5.  Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.

Authors:  F Figen Ayhan-Ardic; Oznur Oken; Z Rezan Yorgancioglu; Nilgun Ustun; F Dilek Gokharman
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

6.  Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.

Authors:  Jeffrey A Sparks; Medha Barbhaiya; Elizabeth W Karlson; Susan Y Ritter; Soumya Raychaudhuri; Cassandra C Corrigan; Fengxin Lu; Jacob Selhub; Daniel I Chasman; Nina P Paynter; Paul M Ridker; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2017-02-10       Impact factor: 5.532

7.  Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.

Authors:  M Hoekstra; A E van Ede; C J Haagsma; M A F J van de Laar; T W J Huizinga; M W M Kruijsen; R F J M Laan
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

8.  Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma.

Authors:  Mark J Hamblin; Maureen R Horton
Journal:  Pulm Med       Date:  2011-06-04

9.  Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature.

Authors:  Nadia D'Andrea; Luca Triolo; Giovanna Margagnoni; Annalisa Aratari; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2010-10-31

10.  Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  K Visser; W Katchamart; E Loza; J A Martinez-Lopez; C Salliot; J Trudeau; C Bombardier; L Carmona; D van der Heijde; J W J Bijlsma; D T Boumpas; H Canhao; C J Edwards; V Hamuryudan; T K Kvien; B F Leeb; E M Martín-Mola; H Mielants; U Müller-Ladner; G Murphy; M Østergaard; I A Pereira; C Ramos-Remus; G Valentini; J Zochling; M Dougados
Journal:  Ann Rheum Dis       Date:  2008-11-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.